Foyston, Gordon, & Payne Inc Medtronic PLC Transaction History

Foyston, Gordon, & Payne Inc

$396 Million
Q2 2024

A detailed history of Foyston, Gordon, & Payne Inc transactions in Medtronic PLC stock. As of the latest transaction made, Foyston, Gordon, & Payne Inc holds 187,632 shares of MDT stock, worth $16.6 Million. This represents 3.73% of its overall portfolio holdings.

Number of Shares

187,632

Previous 188,571 0.5%

Holding current value

$16.6 Million

Previous $16.4 Million 10.13%

% of portfolio

3.73%

Previous 4.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$78.71 - $87.02 $73,908 - $81,711	-939 Reduced 0.5%	187,632 $14.8 Million
Q1 2024 May 07, 2024	SELL	$82.84 - $88.09 $352,484 - $374,822	-4,255 Reduced 2.21%	188,571 $16.4 Million
Q4 2023 Feb 07, 2024	BUY	$69.43 - $83.43 $1.44 Million - $1.73 Million	20,775 Added 12.07%	192,826 $15.9 Million
Q3 2023 Oct 26, 2023	SELL	$78.22 - $90.4 $1.07 Million - $1.23 Million	-13,638 Reduced 7.34%	172,051 $13.5 Million
Q2 2023 Aug 01, 2023	BUY	$79.47 - $91.38 $1.04 Million - $1.2 Million	13,097 Added 7.59%	185,689 $16.4 Million
Q1 2023 May 03, 2023	BUY	$76.72 - $87.58 $843,459 - $962,854	10,994 Added 6.8%	172,592 $13.9 Million
Q4 2022 Feb 09, 2023	BUY	$76.18 - $87.74 $1.83 Million - $2.1 Million	23,962 Added 17.41%	161,598 $12.6 Million
Q3 2022 Nov 04, 2022	BUY	$80.75 - $95.31 $3.19 Million - $3.76 Million	39,448 Added 40.18%	137,636 $11.1 Million
Q2 2022 Aug 11, 2022	SELL	$87.4 - $113.09 $4.06 Million - $5.26 Million	-46,510 Reduced 32.14%	98,188 $8.81 Million
Q1 2022 Apr 27, 2022	SELL	$100.58 - $112.38 $2.35 Million - $2.62 Million	-23,318 Reduced 13.88%	144,698 $16.1 Million
Q4 2021 Feb 11, 2022	SELL	$99.53 - $127.75 $1.54 Million - $1.97 Million	-15,449 Reduced 8.42%	168,016 $17.4 Million
Q3 2021 Nov 12, 2021	SELL	$122.75 - $135.17 $910,805 - $1 Million	-7,420 Reduced 3.89%	183,465 $23 Million
Q2 2021 Aug 06, 2021	SELL	$118.19 - $131.5 $2.27 Million - $2.53 Million	-19,233 Reduced 9.15%	190,885 $23.7 Million
Q1 2021 May 14, 2021	SELL	$111.18 - $119.74 $1.35 Million - $1.46 Million	-12,183 Reduced 5.48%	210,118 $24.8 Million
Q4 2020 Feb 12, 2021	SELL	$100.57 - $117.14 $1.15 Million - $1.34 Million	-11,443 Reduced 4.9%	222,301 $26 Million
Q3 2020 Nov 12, 2020	SELL	$90.13 - $108.78 $2.82 Million - $3.4 Million	-31,270 Reduced 11.8%	233,744 $24.3 Million
Q2 2020 Aug 14, 2020	SELL	$84.11 - $103.33 $3.72 Million - $4.57 Million	-44,211 Reduced 14.3%	265,014 $24.3 Million
Q1 2020 May 15, 2020	SELL	$72.92 - $121.3 $5.71 Million - $9.5 Million	-78,355 Reduced 20.22%	309,225 $27.9 Million
Q4 2019 Feb 14, 2020	SELL	$104.49 - $114.54 $571,037 - $625,961	-5,465 Reduced 1.39%	387,580 $44 Million
Q3 2019 Nov 14, 2019	SELL	$98.02 - $111.18 $2.62 Million - $2.97 Million	-26,714 Reduced 6.36%	393,045 $42.7 Million
Q2 2019 Aug 15, 2019	BUY	$84.15 - $99.38 $315,730 - $372,873	3,752 Added 0.9%	419,759 $40.9 Million
Q1 2019 May 14, 2019	BUY	$82.45 - $93.79 $224,181 - $255,015	2,719 Added 0.66%	416,007 $37.9 Million
Q4 2018 Feb 08, 2019	SELL	$85.8 - $99.49 $6.06 Million - $7.03 Million	-70,645 Reduced 14.6%	413,288 $37.6 Million
Q3 2018 Nov 02, 2018	SELL	$85.91 - $99.17 $1.22 Million - $1.41 Million	-14,237 Reduced 2.86%	483,933 $47.6 Million
Q2 2018 Aug 10, 2018	BUY	$77.48 - $87.83 $1.14 Million - $1.29 Million	14,674 Added 3.03%	498,170 $42.6 Million
Q1 2018 May 14, 2018	BUY	$76.55 - $87.26 $743,530 - $847,556	9,713 Added 2.05%	483,496 $38.8 Million
Q4 2017 Feb 14, 2018	SELL	$76.93 - $83.5 $6.92 Million - $7.51 Million	-89,937 Reduced 15.95%	473,783 $38.3 Million
Q3 2017 Nov 14, 2017	BUY	$77.71 - $84.6 $12.5 Million - $13.6 Million	160,884 Added 39.94%	563,720 $43.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	402,836	402,836 $35.8 Million

Others Institutions Holding MDT

# of Institutions

2,222

Shares Held

1.04B

Call Options Held

7.09M

Put Options Held

4.39M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $117B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Foyston, Gordon, & Payne Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foyston, Gordon, & Payne Inc with notifications on news.

Account

Foyston, Gordon, & Payne Inc Medtronic PLC Transaction History